Abbott J, Berrington J, Bowler U, Boyle E, Dorling J, Embleton N, Juszczak E, Leaf A, Linsell L, Johnson S, McCormick K, McGuire W, Roberts T, Stenson B; Sift Investigators Group. The Speed of Increasing milk Feeds: a randomised controlled trial. BMC Pediatr 201728;17:39

Corbett MS, Webster A, Hawkins R, Woolacott N. Innovative regenerative medicines in the EU: a better future in evidence? BMC Medicine 2017;15:49

Devane D, Lalor JG, Daly S, McGuire W, Cuthbert A, Smith V. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews 2017, Issue 1 Art. No.:CD005122. DOI: 10.1002/14651858.CD005122.pub5

Hemming V, Jakes AD, Shenton G, Phillips B. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropeniaBMC Pediatr 2017;17:2

Hettle R, Corbett M, Hinde S, Hodgson R, Jones-Diette J, Woolacott N, Palmer S. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal. Health Technol Assess 2017;21:1-204

Low J, Ross JS, Ritchie JD, Gross CP, Lehman R, Lin H, Fu R, Stewart LA, Krumholz HM. Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project. Syst Rev 2017;6:28

MacPherson H, Vickers A, Bland M, Torgerson D, Corbett M, Spackman E, Saramago P, Woods B, Weatherly H, Sculpher M, Manca A, Richmond S, Hopton A, Eldred J, Watt I. Acupuncture for chronic pain and depression in primary care: a programme of researchProgramme Grants Appl Res 2017;5(3)

Meader N, King K, Wright K, Graham HM, Petticrew M, Power C, White M, Sowden AJ. Multiple risk behavior interventions: meta-analyses of RCTsAm J Prev Med 2017;DOI:10.1016/j.amepre.2017.01.032

Morgan JE, Hassan H, Cockle JV, Lethaby C, James B, Phillips RS. Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology. Supportive Care in Cancer 2017;25:221-8

Morgan P, Woolacott N, Biswas M, Mebrahtu T, Harden M, Hodgson R. Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer: an Evidence Review Group perspective of a NICE Single Technology Appraisal. PharmacoEconomics 2017. doi:10.1007/s40273-017-0497-1 

Proudfoot R, Phillips B, Wilne S. Guidelines for the prophylaxis of Pneumocystis Jirovecii Pneumonia (PJP) in children with solid tumors. J Pediatr Hematol Oncol. 2017 Mar 6 [Epub ahead of print]

Wilson PM, Farley K, Bickerdike L, Booth A, Chambers D, Lambert M, Thompson C, Turner R, Watt IS. Effects of a demand-led evidence briefing service on the uptake and use of research evidence by commissioners of health services: a controlled before-and-after study. Health Serv Deliv Res 2017;5(5)

Wilson PM, Farley K, Bickerdike L, Booth A, Chambers D, Lambert M, Thompson C, Turner R, Watt IS. Does access to a demand-led evidence briefing service improve uptake and use of research evidence by health service commissioners? A controlled before and after study. Implement Sci 2017;12:20

Woods B, Manca A, Weatherly H, Saramago P, Sideris E, Giannopoulou C, Rice S, Corbett M, Vickers A, Bowes M, MacPherson H, Sculpher M. Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee. PLoS One 2017;12:e0172749.